During the past decade, Klein and Associates MD, PA conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 27 clinical trials were completed, i.e. on average, 135% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 14 clinical trials were completed. i.e. 280% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Klein and Associates MD, PA" #1 sponsor was "Eli Lilly and Company" with 8 trials, followed by "Bristol-Myers Squibb" with 7 trials sponsored, "Boehringer Ingelheim" with 3 trials sponsored, "Amgen" with 2 trials sponsored and "Galapagos NV" with 2 trials sponsored. Other sponsors include 18 different institutions and companies that sponsored additional 24 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Klein and Associates MD, PA" #1 collaborator was "GlaxoSmithKline" with 1 trials as a collaborator, "Incyte Corporation" with 1 trials as a collaborator, "Laboratory Corporation of America" with 1 trials as a collaborator, "Mene Research" with 1 trials as a collaborator and "Novartis Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Klein and Associates MD, PA" are "Rheumatoid Arthritis" (15 trials), "Arthritis, Rheumatoid" (6 trials), "Osteoporosis" (5 trials), "Psoriatic Arthritis" (4 trials) and "Axial Spondyloarthritis" (2 trials). Many other conditions were trialed in "Klein and Associates MD, PA" in a lesser frequency.

Most popular intervention types in "Klein and Associates MD, PA" are "Drug" (41 trials), "Biological" (4 trials), "Other" (3 trials), "Diagnostic Test" (1 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (22 trials), "Ixekizumab" (5 trials), "Abatacept" (4 trials), "Adalimumab" (3 trials) and "Zoledronic Acid" (3 trials). Other intervention names were less common.

The vast majority of trials in "Klein and Associates MD, PA" are 40 trials for "All" genders, 4 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Klein and Associates MD, PA". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 36 completed trials in Klein and Associates MD, PA, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Klein and Associates MD, PA, 1 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 29 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 0 trials that are defined as “Not Applicable".